Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001104659-24-113998
Filing Date
2024-11-04
Accepted
2024-11-04 19:39:44
Documents
2
Group Members
MARK ANGELOSC-SIGMA GLOBAL PARTNERS, LPYA GLOBAL INVESTMENTS II (U.S.), LPYAII GP II, LLCYAII GP, LPYORKVILLE ADVISORS GLOBAL II, LLCYORKVILLE ADVISORS GLOBAL, LP

Document Format Files

Seq Description Document Type Size
1 SC 13G/A tm2427411d6_sc13ga.htm SC 13G/A 114972
2 EXHIBIT 99.1 tm2427411d6_ex99-1.htm EX-99.1 12067
  Complete submission text file 0001104659-24-113998.txt   129062
Mailing Address 101 HUDSON STREET #3700 JERSEY CITY NJ 07302
Business Address 101 HUDSON STREET #3700 JERSEY CITY NJ 07302 201 985 8300
YA II PN, Ltd. (Filed by) CIK: 0001463928 (see all company filings)

EIN.: 980615492 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address THE CIRCLE 6 8058 ZURICH V8 CH-6370
Business Address THE CIRCLE 6 8058 ZURICH V8 CH-6370 41-41-618-80-00
NLS Pharmaceutics Ltd. (Subject) CIK: 0001783036 (see all company filings)

EIN.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-92065 | Film No.: 241425217
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)